Curaleaf (OTCMKTS:CURLF) is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.
Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates. The company also offers proprietary CBD wellness products designed to address pain relief, stress management and sleep support. Curaleaf’s dispensaries provide personalized consultation services, allowing both medical patients and adult-use consumers to select products best suited to their needs. In addition, Curaleaf supplies wholesale products to other licensed retailers in states where it holds cultivation and processing licenses.
Founded in 2010, Curaleaf has expanded through strategic acquisitions, including the 2019 purchase of Grassroots Cannabis and the 2020 acquisition of Select, a premium U.S. cannabis oil brand. These transactions have broadened the company’s geographic footprint and product capabilities. Under the leadership of CEO Matt Darin, Curaleaf continues to pursue disciplined growth, regulatory compliance and innovation in cannabinoid research to support its long-term vision of becoming the most trusted brand in global cannabis.
